Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NHWK

NHWK - NightHawk Biosciences, Inc. Stock Price, Fair Value and News

$0.16 
Market Closed

Price Targets

NHWK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NHWK Price Action

NHWK RSI Chart

NHWK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NHWK Valuation

Market Cap

9.8M

Price/Earnings (Trailing)

-0.29

Price/Sales (Trailing)

4.06

EV/EBITDA

-0.33

Price/Free Cashflow

-0.45

NHWK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

NHWK Fundamentals

NHWK Revenue

Revenue (TTM)

2.4M

Rev. Growth (Yr)

-70.06%

Rev. Growth (Qtr)

7.19%

NHWK Earnings

Earnings (TTM)

-34.3M

Earnings Growth (Yr)

54.02%

Earnings Growth (Qtr)

61.92%

NHWK Profitability

EBT Margin

-1494.15%

Return on Equity

433.25%

Return on Assets

-159.07%

Free Cashflow Yield

-222.82%

NHWK Investor Care

Shares Dilution (1Y)

1102.82%

Diluted EPS (TTM)

18.81

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.9M2.4M00
20249.7M9.8M10.0M6.2M
2023939.7K1.5M2.2M7.0M
20221.8M1.4M935.4K386.2K
20212.6M2.5M2.1M2.1M
20203.2M3.5M4.3M2.9M
20195.7M4.9M3.1M3.0M
20182.2M3.0M4.3M5.8M
2017636.2K930.8K1.2M1.5M
201643.3K142.7K242.2K341.6K
201538.7K000
201417.7K25.3K32.9K40.6K
201300010.1K
20120003.1K
Get all data in R, Python etc through our Historical Stock Data APIs

About NightHawk Biosciences, Inc.

NHWK
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
 CEO
 WEBSITEnighthawkbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES77

NightHawk Biosciences, Inc. Frequently Asked Questions

NHWK is the stock ticker symbol of NightHawk Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Dec 31 2025, market cap of NightHawk Biosciences, Inc. is 9.78 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NHWK's fair value in chart for subscribers.

The fair value guage provides a quick view whether NHWK is over valued or under valued. Whether NightHawk Biosciences, Inc. is cheap or expensive depends on the assumptions which impact NightHawk Biosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NHWK.

As of Wed Dec 31 2025, NHWK's PE ratio (Price to Earnings) is -0.29 and Price to Sales (PS) ratio is 4.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NHWK PE ratio will change depending on the future growth rate expectations of investors.